Buprenorphine Training Activity

Start the Activity!

This online DATA 2000 compliant training activity meets the educational requirements to start prescribing buprenorphine for your patients with opioid addiction! This activity has NO industry support, pharmacological or other.

Activity Information

Professional Practice Gap

In 2015, The Substance Abuse and Mental Health Services Administration (SAMHSA) estimated that 828,000 people used heroin. And 12.5 million people misused prescription pain relievers; representing nearly 13% of those who had reported using them this year. In fact, these figures probably vastly underestimate the true prevalence of opioid use disorders in the United States. Further, only a small fraction of these users have received treatment for opioid use disorder (SAMHSA, 2013).

Buprenorphine is a safe and effective treatment for opioid dependence that offers patients a more widely available, accessible, convenient treatment option as compared to traditional opioid treatment activities (OTP) (SAMHSA, 2001; Johnson et al., 2003; SAMHSA, 2004). The Drug Addiction Treatment Act (DATA) of 2000 -- an amendment to the Controlled Substances Act -- allows physicians who are not part of an OTP to prescribe buprenorphine. However, the law requires physicians to complete an 8-hour buprenorphine training conducted by an approved organization in order to prescribe it.

This buprenorphine training activity prepares physicians to prescribe buprenorphine safely and effectively to address needs of the millions of Americans with opioid use problems. In addition, the activity has been developed to meet the DATA 2000 training guidelines as defined in Public Law 106-310-106th Congress and is endorsed by the American Society of Addiction Medicine, one of the approved training organizations named in DATA 2000. The activity content is based upon SAMHSA’s 2004 publication Treatment Improvement Protocol (TIP) #40: Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. The courses are regularly reviewed and updated by ASAM members who are experts in the field of addiction medicine and buprenorphine treatment.


Hughes A, Williams MR, Lipari RN, et al. Prescription Drug Use and Misuse in the United States: Results from the 2015 National Survey on Drug Use and Health. SAMHSA. 2016. Available at: http://www.samhsa.gov/data/sites/default/files/NSDUH-FFR2-2015/NSDUH-FFR2-2015.htm Accessed on: 2016-09-13.

Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depend. 2003; 70(suppl 2): S59-S77. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12738351.

Substance Abuse and Mental Health Services Administration (SAMHSA). Use of Buprenorphine in the Pharmacologic Management of Opioid Dependence: A Curriculum for Physicians. Substance Abuse and Mental Health Services Administration. 2001. Available at: http://www.buprenorphine.samhsa.gov/Buprenorphine_Curriculum.pdf.

Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, Md: Center For Substance Abuse Treatment. Treatment Improvement Protocol Series, No. 40, USDHHS Publication (SMA) 04-3939. 2004. Available at: http://buprenorphine.samhsa.gov/Bup_Guidelines.pdf.

Substance Abuse and Mental Health Services Administration (SAMHSA). Overview of Findings From the 2004 National Survey on Drug Use and Health. Rockville, Md: Office of Applied Studies. 2005. Available at: http://oas.samhsa.gov/NSDUH/2k4NSDUH/2k4Overview/2k4Overview.pdf.

Goal/Expected Learner Outcome

To provide training to physicians that meets the requirement of DATA 2000, in order to increase the number of physicians who are knowledgeable about and qualified to prescribe buprenorhpine to their opioid-dependent patients.

Participation and Technical Requirements

Credit: Obtaining credit for participation in this activity requires that you complete the pre-assessments, work through the modules (including all in-module interactive activities), complete the post-assessments with a 70% score on the post-test, and then request credit. At the end of the activity, you will be instructed on how to print out a certificate for your records. Time Requirement: Keep track of the amount of time it takes you to complete this activity. You will be required to spend a set amount of time in order to claim credit. You should claim credit only for the time actually spent in the activity. Technical Requirements: To participate in this activity, you will need a computer, an Internet connection, and a Web browser. This activity requires Chrome, Firefox, and IE7 or higher.

This activity is designed to change competence and performance.


  1. Pharmacology of Buprenorphine and Other Opioids:Understand the pharmacological basis of opioids and buprenorphine.
  2. Detection and Diagnosis of Opioid Use Disorder: Understand how to interact with patients and screen for and recognize opioid use disorder.
  3. Assessment for Office-Based Treatment: Understand which patients are most suitable for office-based buprenorphine treatment.
  4. Buprenorphine Protocol: Induction: Be able to initiate and maintain patients on buprenorphine safely.
  5. Buprenorphine Protocols: Maintenance and Discontinuation: Be able to maintain patients on buprenorphine, and deal with special situations in buprenorphine treatment.
  6. Office-Based Opioid Treatment: Understand the regulations and requirements of office-based buprenorphine treatment.
  7. Buprenorphine Protocols: Methadone Patients and Other Special Populations: Be able to safely initiate and maintain special populations on buprenorphine.
  8. Impact of Opioid Addiction: Understand the prevalence of opioid misuse and the impact of opioid use on physical and mental health.
  9. Managing Patients with Substance Use Disorders in Clinical Practice: Understand how to manage problematic behaviors and how to measure treatment efficacy using urine screening.


To complete the activity:
  • Complete the pre-assessments
  • Complete all modules and in-module activities
  • Complete post assessments with a 70% score on post test
  • Print completion certificate
  • Apply online or by mail for your waiver from SAMHSA


  • 8 hour training activity meets the training requirement of DATA 2000
  • All internet-based, available 24/7
  • Interactive cases
  • Up to 9 AMA PRA Category 1 Credits (TM) available for physicians

Accreditation Statement

  • Credit Statement for AMA PRA Category 1 Credit(s)™: Clinical Tools, Inc designates this enduring material for a maximum of 9.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Release: 4/23/13 Expiration: 4/23/15 Estimated time: 9 hours
  • Designation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) by Clinical Tools, Inc. Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
  • A letter of completion is available for other non-physicians.

Target Audience

Physicians, Nurse Practitioners, and Physician Assistants who can prescribe narcotics

Authors & Reviewer Information

As an ACCME accredited provider of continuing medical education, Clinical Tools, Inc. complies with the Standards for Commercial Support issued by the ACCME and requires disclosure of and resolution of any conflicts of interest for those in control of content.
  • Author: T Bradley Tanner, MD (President, Clinical Tools, Inc.)
  • Author: Karen Rossie, PhD DDS MS (Research Scientist, Clinical Tools, Inc.)
  • Reviewer: Steve Applegate, MEd MEd (President, Applegate Consulting)
Dr. Tanner, Dr. Rossie and Mr. Applegate have disclosed no relevant financial relationships.

Cost Structure

  • Up to 4 individuals: $199/provider
  • 5-9 people: $175/provider
  • 10+ people: $150/provider
  • Residents/ Nurses: $100/person
  • Complete the Follow-up assessments to receive a $25 refund or credit
Initial development of this activity was supported by a grant from the National Institute on Drug Abuse (#R44-DA12066).

Educational Objectives

Buprenorphine Drug Addiction Treatment Act of 2000 (DATA 2000) Training Activity: What Will I Learn?
  • Expand your practice to comply with the regulations and requirements of office based buprenorphine treatment so that you can prescribe buprenorphine to your patients when appropriate
  • Relate buprenorphine's pharmacological properties to its drug effects and understand the physiological effects of opioids and opioid treatments on patients
  • Use medical and substance abuse history information to assess your patients in terms of suitability of treatment with buprenorphine
  • Provide effective and successful treatment to your patients throughout the phases of buprenorphine treatment: induction, maintenance, and discontinuation, and deal with complications that arise
  • Assess and adapt treatment guidelines to best treat your patients from specific patient populations, including those with psychiatric comorbidities, adolescents, the elderly, pregnant women, methadone transfers, and patients with pain
  • Prescribe, refer, or implement appropriate psychosocial therapies for treating opioid dependence for your patients

Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.